ASTRO 2021: Pembrolizumab + CCRT Continues to Hold Promise Against Untreated, Locally Advanced, Stage 3 NSCLC
Updated follow-up was reported.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Updated follow-up was reported.
Only registered members have full access to PracticeUpdate content.